, 1:1000) (Figs 2D-F). Taken together, these experiments suggest that Env-EL9-specific CD8+

S. A. Migueles, M. Connors, R. A. Kaslow, M. Carrington, R. Apple et al., Long-term nonprogressive disease among untreated 2, p.33, 2010.

R. P. Payne, H. Kloverpris, J. B. Sacha, Z. Brumme, C. Brumme et al., , vol.2, 2010.

R. D. Salter, D. N. Howell, and P. Cresswell, Genes regulating HLA class I antigen 60. LLano A FN, Brander C. 2009. How to Optimally Define Optimal Cytotoxic T 38, 1985.

J. M. Carlson, C. J. Brumme, E. Martin, J. Listgarten, M. A. Brockman et al., HIV transmission. Selection bias at the 1061 heterosexual HIV-1 transmission bottleneck, Science, vol.345, pp.1254031-1062, 2014.

P. C. Matthews, A. Prendergast, A. Leslie, H. Crawford, R. Payne et al., Central role of 1065 reverting mutations in HLA associations with human immunodeficiency virus set point, J 1066 Virol, vol.82, pp.8548-8559, 2008.

M. Dibrino, K. C. Parker, D. H. Margulies, J. Shiloach, R. V. Turner et al.,

C. L. Boutwell, J. M. Carlson, T. H. Lin, A. Seese, K. A. Power et al., Heterogeneity in HIV suppression by CD8 T cells from HIV 1077 controllers: association with Gag-specific CD8 T cell responses, J Immunol, vol.72, pp.7828-1078, 2009.

Y. Riviere, M. B. Mcchesney, F. Porrot, F. Tanneau-salvadori, P. Sansonetti et al., specific cytotoxic responses to HIV type 1 are associated with a decreased risk of 1082 progression to AIDS-related complex or AIDS, AIDS Res Hum Retroviruses, vol.11, p.74

M. R. Klein, C. A. Van-baalen, A. M. Holwerda, K. Garde, S. R. Bende et al., HIV-1 infection: a longitudinal analysis of rapid progressors and long-term 1087 asymptomatics, J Exp Med, vol.181, pp.1365-1372

G. S. Ogg, J. X. Bonhoeffer, S. Dunbar, P. R. Nowak, M. A. Monard et al., , vol.84

H. Jessen, T. M. Allen, and H. Streeck, How a single patient influenced HIV research, 2014.

O. O. Yang, S. A. Kalams, A. Trocha, H. Cao, A. Luster et al., evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms, J 1143 Virol, vol.71, pp.3120-3128, 1997.

D. Y. Chen, A. Balamurugan, H. L. Ng, O. O. Yang, S. A. Migueles et al., Antiviral activity of human 1145 immunodeficiency virus type 1 Gag-specific cytotoxic T lymphocyte targeting is not 1146 necessarily intrinsically superior to envelope targeting, J Virol, vol.85, pp.2474-2478, 1147.

T. P. Garrett, M. A. Saper, P. J. Bjorkman, J. L. Strominger, and D. C. Wiley, Specificity 1168 pockets for the side chains of peptide antigens in HLA-Aw68, Nature, vol.342, p.95, 1989.

M. A. Saper, P. J. Bjorkman, and D. C. Wiley, , 1991.

P. Parham, C. E. Lomen, D. A. Lawlor, J. P. Ways, N. Holmes et al., , 2005.

X. Gao, G. W. Nelson, P. Karacki, M. P. Martin, J. Phair et al.,